Published in Annu Rev Public Health on January 01, 2010
Next generation genome-wide association tool: design and coverage of a high-throughput European-optimized SNP array. Genomics (2011) 2.31
Stitching together multiple data dimensions reveals interacting metabolomic and transcriptomic networks that modulate cell regulation. PLoS Biol (2012) 1.82
What is personalized medicine and what should it replace? Nat Rev Gastroenterol Hepatol (2012) 1.38
The contribution of genetic variants to disease depends on the ruler. Nat Rev Genet (2014) 1.16
Polygenic modeling of genome-wide association studies: an application to prostate and breast cancer. OMICS (2011) 1.02
HOXB13 mutation and prostate cancer: studies of siblings and aggressive disease. Cancer Epidemiol Biomarkers Prev (2013) 1.00
A systematic review of cancer GWAS and candidate gene meta-analyses reveals limited overlap but similar effect sizes. Eur J Hum Genet (2013) 0.98
From integrative disease modeling to predictive, preventive, personalized and participatory (P4) medicine. EPMA J (2013) 0.98
A robust model-free approach for rare variants association studies incorporating gene-gene and gene-environmental interactions. PLoS One (2013) 0.96
Calling amplified haplotypes in next generation tumor sequence data. Genome Res (2011) 0.95
The impact of improved microarray coverage and larger sample sizes on future genome-wide association studies. Genet Epidemiol (2013) 0.94
Structural bioinformatics of the interactome. Annu Rev Biophys (2014) 0.93
Unravelling the human genome-phenome relationship using phenome-wide association studies. Nat Rev Genet (2016) 0.92
Overview of the symposium on public health significance of genomics and eco-genetics. Annu Rev Public Health (2010) 0.89
Bridging the Gap between Genotype and Phenotype via Network Approaches. Front Genet (2013) 0.88
Framework for interpretation of genetic variations in pancreatitis patients. Front Physiol (2012) 0.87
Identifying Novel Gene Variants in Coronary Artery Disease and Shared Genes With Several Cardiovascular Risk Factors. Circ Res (2015) 0.84
A hybrid likelihood model for sequence-based disease association studies. PLoS Genet (2013) 0.83
Future possibilities in migraine genetics. J Headache Pain (2012) 0.82
Case-only exome sequencing and complex disease susceptibility gene discovery: study design considerations. J Med Genet (2014) 0.80
LocusTrack: Integrated visualization of GWAS results and genomic annotation. Source Code Biol Med (2015) 0.80
How far from the SNP may the causative genes be? Nucleic Acids Res (2016) 0.79
Strategies for Imputing and Analyzing Rare Variants in Association Studies. Trends Genet (2015) 0.79
This I believe: gaining new insights through integrating "old" data. Front Genet (2012) 0.77
Genome-wide association study heterogeneous cohort homogenization via subject weight knock-down. PLoS One (2012) 0.77
Population genetic simulations of complex phenotypes with implications for rare variant association tests. Genet Epidemiol (2014) 0.77
Rare genetic variants and treatment response: sample size and analysis issues. Stat Med (2012) 0.77
An integrative data analysis platform for gene set analysis and knowledge discovery in a data warehouse framework. Database (Oxford) (2016) 0.76
Association between functional polymorphisms in genes involved in the MAPK signaling pathways and cutaneous melanoma risk. Carcinogenesis (2013) 0.76
To control false positives in gene-gene interaction analysis: two novel conditional entropy-based approaches. PLoS One (2013) 0.75
A Quantitative Genomic Approach for Analysis of Fitness and Stress Related Traits in a Drosophila melanogaster Model Population. Int J Genomics (2016) 0.75
Parallel biocomputing. Source Code Biol Med (2011) 0.75
The complex genetics of gait speed: genome-wide meta-analysis approach. Aging (Albany NY) (2017) 0.75
Weighted SNP set analysis in genome-wide association study. PLoS One (2013) 0.75
Initial sequencing and analysis of the human genome. Nature (2001) 212.86
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature (2007) 144.95
Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet (2006) 115.71
A haplotype map of the human genome. Nature (2005) 105.70
The sequence of the human genome. Science (2001) 101.55
Statistical significance for genomewide studies. Proc Natl Acad Sci U S A (2003) 88.64
A second generation human haplotype map of over 3.1 million SNPs. Nature (2007) 85.39
Construction of a genetic linkage map in man using restriction fragment length polymorphisms. Am J Hum Genet (1980) 75.25
The International HapMap Project. Nature (2003) 73.65
The future of genetic studies of complex human diseases. Science (1996) 64.76
Genomic control for association studies. Biometrics (1999) 64.39
Global variation in copy number in the human genome. Nature (2006) 57.50
Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A (2009) 54.68
A new multipoint method for genome-wide association studies by imputation of genotypes. Nat Genet (2007) 52.68
The structure of haplotype blocks in the human genome. Science (2002) 50.88
Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet (2008) 30.94
Genome-wide association study identifies novel breast cancer susceptibility loci. Nature (2007) 29.23
Efficiency and power in genetic association studies. Nat Genet (2005) 25.56
Population structure, differential bias and genomic control in a large-scale, case-control association study. Nat Genet (2005) 25.34
Use of unlinked genetic markers to detect population stratification in association studies. Am J Hum Genet (1999) 23.67
Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet (2007) 21.18
Common genetic variation and human traits. N Engl J Med (2009) 21.03
High-resolution haplotype structure in the human genome. Nat Genet (2001) 20.51
A groupwise association test for rare mutations using a weighted sum statistic. PLoS Genet (2009) 19.64
Personal genomes: The case of the missing heritability. Nature (2008) 19.56
Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat Genet (2007) 19.18
Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst (2004) 19.00
A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science (2007) 18.96
Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome. Science (1998) 18.23
A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature (2008) 18.21
Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet (2008) 17.65
Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet (2006) 17.36
A comprehensive review of genetic association studies. Genet Med (2002) 16.75
Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet (2003) 16.51
On the allelic spectrum of human disease. Trends Genet (2001) 16.26
Replicating genotype-phenotype associations. Nature (2007) 16.11
Common deletion polymorphisms in the human genome. Nat Genet (2006) 15.66
Cumulative association of five genetic variants with prostate cancer. N Engl J Med (2008) 15.34
Genetic mapping in human disease. Science (2008) 15.12
Evaluating and improving power in whole-genome association studies using fixed marker sets. Nat Genet (2006) 14.76
Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes. Nat Genet (2007) 12.65
Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity. Nat Genet (2008) 12.43
A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21. Nat Genet (2007) 11.62
Estimation of the multiple testing burden for genomewide association studies of nearly all common variants. Genet Epidemiol (2008) 11.28
The new genomics: global views of biology. Science (1996) 10.77
Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24. Nat Genet (2007) 9.88
Common deletions and SNPs are in linkage disequilibrium in the human genome. Nat Genet (2005) 9.61
Genetic determinants of hair, eye and skin pigmentation in Europeans. Nat Genet (2007) 8.79
Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet (2008) 7.65
Common sequence variants in the LOXL1 gene confer susceptibility to exfoliation glaucoma. Science (2007) 7.55
Genotype-imputation accuracy across worldwide human populations. Am J Hum Genet (2009) 7.28
The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer. Nat Genet (2009) 6.99
Sequence variant on 8q24 confers susceptibility to urinary bladder cancer. Nat Genet (2008) 6.69
Multiple genetic loci for bone mineral density and fractures. N Engl J Med (2008) 6.35
Point: population stratification: a problem for case-control studies of candidate-gene associations? Cancer Epidemiol Biomarkers Prev (2002) 6.00
The limitations of risk factors as prognostic tools. N Engl J Med (2006) 5.90
The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling. Nat Genet (2009) 5.65
An open access database of genome-wide association results. BMC Med Genet (2009) 4.61
Validating, augmenting and refining genome-wide association signals. Nat Rev Genet (2009) 4.56
A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose. PLoS Genet (2009) 4.32
On the use of general control samples for genome-wide association studies: genetic matching highlights causal variants. Am J Hum Genet (2008) 3.95
Selection of controls in case-control studies. I. Principles. Am J Epidemiol (1992) 3.94
Probing genetic overlap among complex human phenotypes. Proc Natl Acad Sci U S A (2007) 3.79
Recent developments in genomewide association scans: a workshop summary and review. Am J Hum Genet (2005) 3.76
Betting odds and genetic associations. J Natl Cancer Inst (2004) 3.39
Asymptotic bias and efficiency in case-control studies of candidate genes and gene-environment interactions: basic family designs. Am J Epidemiol (1999) 3.31
Curses--winner's and otherwise--in genetic epidemiology. Epidemiology (2008) 3.19
Multiple novel prostate cancer predisposition loci confirmed by an international study: the PRACTICAL Consortium. Cancer Epidemiol Biomarkers Prev (2008) 3.05
Beyond odds ratios--communicating disease risk based on genetic profiles. Nat Rev Genet (2009) 3.01
Genome-wide association study identifies sequence variants on 6q21 associated with age at menarche. Nat Genet (2009) 2.58
Enriching the analysis of genomewide association studies with hierarchical modeling. Am J Hum Genet (2007) 2.32
Collaborative genome-wide association studies of diverse diseases: programs of the NHGRI's office of population genomics. Pharmacogenomics (2009) 2.23
Prostate cancer genomics: towards a new understanding. Nat Rev Genet (2008) 2.08
Methods for investigating gene-environment interactions in candidate pathway and genome-wide association studies. Annu Rev Public Health (2010) 1.88
The regulation of direct-to-consumer genetic tests. Hum Mol Genet (2008) 1.77
Genetic dissection of complex traits. Nat Genet (1996) 1.72
A gene-centric approach to genome-wide association studies. Nat Rev Genet (2006) 1.72
Population genomics: laying the groundwork for genetic disease modeling and targeting. Clin Chem Lab Med (1998) 1.59
Efficient association mapping of quantitative trait loci with selective genotyping. Am J Hum Genet (2007) 1.55
Comparing algorithms for genotype imputation. Am J Hum Genet (2008) 1.54
Coverage and power in genomewide association studies. Am J Hum Genet (2006) 1.53
From human genetics and genomics to pharmacogenetics and pharmacogenomics: past lessons, future directions. Drug Metab Rev (2008) 1.35
On the relative sample size required for multiple comparisons. Stat Med (2000) 1.06
The environmental genome project: reference polymorphisms for drug metabolism genes and genome-wide association studies. Drug Metab Rev (2008) 0.91
Partitioning the population attributable fraction for a sequential chain of effects. Epidemiol Perspect Innov (2008) 0.85
Genome-wide association studies of cancer. Future Oncol (2007) 0.84